Literature DB >> 27509378

Acute Lymphoblastic Leukemia Presenting With Pancytopenia Followed by a 14-Month-Long Period of Transient Remission Possibly Supporting the Adrenal Hypothesis of Leukemogenesis.

Line Stensig Lynggaard1, Hanne V Marquart, Eigil Kjeldsen, Hans O Madsen, Henrik Hasle.   

Abstract

A small group of children with acute lymphoblastic leukemia (ALL) have a preleukemic phase of pancytopenia followed by a period of spontaneous remission before the diagnosis (pre-ALL). A 6-year-old girl presented with pancytopenia, fever, and myelodysplasia. Following transient remission pre-B ALL was diagnosed 14 months later. Clonal B-lineage blasts at the period of pancytopenia were identified retrospectively. The interval between pre-ALL and ALL-diagnosis was longer than previously reported. The infection was clinically severe and might have induced a significant endogenous corticosteroids production resulting in the long-lasting remission. The case supports the adrenal and the Coley's toxin hypothesis in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27509378     DOI: 10.1097/MPH.0000000000000648

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Spontaneous remission of acute lymphoblastic leukemia: A case report.

Authors:  Timm Höres; Knut Wendelin; Kerstin Schaefer-Eckart
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

2.  Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.

Authors:  Zhongbo Hu; Kristen A VanHeyst; Jignesh Dalal; Lisa Hackney
Journal:  Clin Case Rep       Date:  2021-02-12

3.  Transient bone marrow hypoplasia preceding T-Cell acute lymphoblastic leukemia: a case report.

Authors:  Ernest Naturinda; Paul George; Joseph Ssenyondwa; Deogratias Bakulumpagi; Joseph Lubega; Peter Wasswa
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.